239 related articles for article (PubMed ID: 21917975)
41. Induction of antibodies in rhesus macaques that recognize a fusion-intermediate conformation of HIV-1 gp41.
Dennison SM; Sutherland LL; Jaeger FH; Anasti KM; Parks R; Stewart S; Bowman C; Xia SM; Zhang R; Shen X; Scearce RM; Ofek G; Yang Y; Kwong PD; Santra S; Liao HX; Tomaras G; Letvin NL; Chen B; Alam SM; Haynes BF
PLoS One; 2011; 6(11):e27824. PubMed ID: 22140469
[TBL] [Abstract][Full Text] [Related]
42. Progress towards the development of a HIV-1 gp41-directed vaccine.
McGaughey GB; Barbato G; Bianchi E; Freidinger RM; Garsky VM; Hurni WM; Joyce JG; Liang X; Miller MD; Pessi A; Shiver JW; Bogusky MJ
Curr HIV Res; 2004 Apr; 2(2):193-204. PubMed ID: 15078183
[TBL] [Abstract][Full Text] [Related]
43. Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiency virus type 1 gp41.
Gorny MK; Zolla-Pazner S
J Virol; 2000 Jul; 74(13):6186-92. PubMed ID: 10846104
[TBL] [Abstract][Full Text] [Related]
44. HIV-1 gp41 core with exposed membrane-proximal external region inducing broad HIV-1 neutralizing antibodies.
Wang J; Tong P; Lu L; Zhou L; Xu L; Jiang S; Chen YH
PLoS One; 2011 Mar; 6(3):e18233. PubMed ID: 21483871
[TBL] [Abstract][Full Text] [Related]
45. Identification of variant HIV envelope proteins with enhanced affinities for precursors to anti-gp41 broadly neutralizing antibodies.
Zhu H; Mathew E; Connelly SM; Zuber J; Sullivan M; Piepenbrink MS; Kobie JJ; Dumont ME
PLoS One; 2019; 14(9):e0221550. PubMed ID: 31504041
[TBL] [Abstract][Full Text] [Related]
46. Direct antibody access to the HIV-1 membrane-proximal external region positively correlates with neutralization sensitivity.
Chakrabarti BK; Walker LM; Guenaga JF; Ghobbeh A; Poignard P; Burton DR; Wyatt RT
J Virol; 2011 Aug; 85(16):8217-26. PubMed ID: 21653673
[TBL] [Abstract][Full Text] [Related]
47. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
Finnegan CM; Berg W; Lewis GK; DeVico AL
J Virol; 2002 Dec; 76(23):12123-34. PubMed ID: 12414953
[TBL] [Abstract][Full Text] [Related]
48. Antigp41 membrane proximal external region antibodies and the art of using the membrane for neutralization.
Cerutti N; Loredo-Varela JL; Caillat C; Weissenhorn W
Curr Opin HIV AIDS; 2017 May; 12(3):250-256. PubMed ID: 28422789
[TBL] [Abstract][Full Text] [Related]
49. Multifaceted consequences of anti-gp41 monoclonal antibody 2F5 binding to HIV type 1 virions.
Neurath AR; Strick N; Lin K; Jiang S
AIDS Res Hum Retroviruses; 1995 Jun; 11(6):687-96. PubMed ID: 7576928
[TBL] [Abstract][Full Text] [Related]
50. Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens.
Zhang MY; Vu BK; Choudhary A; Lu H; Humbert M; Ong H; Alam M; Ruprecht RM; Quinnan G; Jiang S; Montefiori DC; Mascola JR; Broder CC; Haynes BF; Dimitrov DS
J Virol; 2008 Jul; 82(14):6869-79. PubMed ID: 18480433
[TBL] [Abstract][Full Text] [Related]
51. HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen.
Jardine JG; Ota T; Sok D; Pauthner M; Kulp DW; Kalyuzhniy O; Skog PD; Thinnes TC; Bhullar D; Briney B; Menis S; Jones M; Kubitz M; Spencer S; Adachi Y; Burton DR; Schief WR; Nemazee D
Science; 2015 Jul; 349(6244):156-61. PubMed ID: 26089355
[TBL] [Abstract][Full Text] [Related]
52. Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection.
Alam SM; Scearce RM; Parks RJ; Plonk K; Plonk SG; Sutherland LL; Gorny MK; Zolla-Pazner S; Vanleeuwen S; Moody MA; Xia SM; Montefiori DC; Tomaras GD; Weinhold KJ; Karim SA; Hicks CB; Liao HX; Robinson J; Shaw GM; Haynes BF
J Virol; 2008 Jan; 82(1):115-25. PubMed ID: 17942537
[TBL] [Abstract][Full Text] [Related]
53. Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41.
Montgomery DL; Wang YJ; Hrin R; Luftig M; Su B; Miller MD; Wang F; Haytko P; Huang L; Vitelli S; Condra J; Liu X; Hampton R; Carfi A; Pessi A; Bianchi E; Joyce J; Lloyd C; Geleziunas R; Bramhill D; King VM; Finnefrock AC; Strohl W; An Z
MAbs; 2009; 1(5):462-74. PubMed ID: 20065653
[TBL] [Abstract][Full Text] [Related]
54. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
Bryson S; Julien JP; Isenman DE; Kunert R; Katinger H; Pai EF
J Mol Biol; 2008 Oct; 382(4):910-9. PubMed ID: 18692506
[TBL] [Abstract][Full Text] [Related]
55. Crystal structure of a non-neutralizing antibody to the HIV-1 gp41 membrane-proximal external region.
Nicely NI; Dennison SM; Spicer L; Scearce RM; Kelsoe G; Ueda Y; Chen H; Liao HX; Alam SM; Haynes BF
Nat Struct Mol Biol; 2010 Dec; 17(12):1492-4. PubMed ID: 21076400
[TBL] [Abstract][Full Text] [Related]
56. Elicitation of structure-specific antibodies by epitope scaffolds.
Ofek G; Guenaga FJ; Schief WR; Skinner J; Baker D; Wyatt R; Kwong PD
Proc Natl Acad Sci U S A; 2010 Oct; 107(42):17880-7. PubMed ID: 20876137
[TBL] [Abstract][Full Text] [Related]
57. Association of variations of NAb 2F5 and 4E10 epitopes and disease progression in Chinese antiretroviral treatment-naïve patients infected with HIV-1 clade B'.
Zhang XL; Han XX; Dai D; Bao MJ; Xu DB; Zhang ZN; Wang YN; Zhao M; Bice T; Jiang YJ; Shang H
Chin Med J (Engl); 2010 Dec; 123(23):3406-11. PubMed ID: 22166522
[TBL] [Abstract][Full Text] [Related]
58. Rational design of membrane proximal external region lipopeptides containing chemical modifications for HIV-1 vaccination.
Venditto VJ; Watson DS; Motion M; Montefiori D; Szoka FC
Clin Vaccine Immunol; 2013 Jan; 20(1):39-45. PubMed ID: 23114698
[TBL] [Abstract][Full Text] [Related]
59. Crystallographic definition of the epitope promiscuity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5: vaccine design implications.
Bryson S; Julien JP; Hynes RC; Pai EF
J Virol; 2009 Nov; 83(22):11862-75. PubMed ID: 19740978
[TBL] [Abstract][Full Text] [Related]
60. Transcytosis-blocking abs elicited by an oligomeric immunogen based on the membrane proximal region of HIV-1 gp41 target non-neutralizing epitopes.
Matoba N; Griffin TA; Mittman M; Doran JD; Alfsen A; Montefiori DC; Hanson CV; Bomsel M; Mor TS
Curr HIV Res; 2008 May; 6(3):218-29. PubMed ID: 18473785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
